On January 31, 2021, Fred Knechtel, the Chief Financial Officer, Treasurer, and Secretary of the Company, left the employ of Interpace Biosciences, Inc. and on February 1, 2021 Thomas J. Freeburg, age 53, who has served as the Company's Chief Accounting Officer since October 2017, was appointed as the Company's successor Chief Financial Officer, Treasurer, and Secretary. Prior to serving as the Company's Chief Accounting Officer, Mr. Freeburg was a Managing Member of Cambridge Financial Consultants LLC from 2014 to September 2017.